Microbiology & Pathology in Georgia

Rad Source Technologies is a global manufacturer of X-ray-based irradiation systems for life science research, medical treatment, and industrial applications. The company specializes in non-nuclear irradiator solutions serving diverse markets including blood bank operations, preclinical research, cell culture, cannabis decontamination, nondestructive testing (NDT), and sterile insect technique (SIT) programs. Product portfolio includes the RS 3400 blood irradiator (featuring industry-leading dose uniformity), RS 2000 Q2 small animal research system, RS 1800 Q cell irradiator, RS 2400 Q sterile insect technique system, RS 420 Q+ BOOST cannabis decontamination platform, and NDT 1000 materials inspection imaging system. The company emphasizes X-ray technology as a non-radioactive alternative to gamma irradiation, positioning its systems for regulatory compliance and operational safety. Rad Source maintains a global service and support network with trained technicians for equipment maintenance, calibration, and technical support. The organization serves research institutions, blood banks, cannabis producers, and industrial inspection operations. All systems are designed for dose uniformity, throughput optimization, and application-specific customization. The company publishes peer-reviewed research on X-ray irradiation efficacy and hosts educational webinars on microbial remediation and contamination control.

Viro Research™ manufactures high-quality biological products and reagents for research and in vitro diagnosis of human viral infections, with specialized focus on VZV (varicella-zoster virus) and HSV (herpes simplex virus) detection. The company develops fluorescent antibody-based diagnostic tests that enable rapid, accurate patient diagnosis and guide treatment pathways for physicians and clinical laboratories. Products utilize proprietary monoclonal antibody technology to deliver enhanced diagnostic sensitivity and specificity, particularly for detection of chickenpox, shingles (herpes zoster), and other viral pathogens in clinical specimens and cell culture.

Alpha Omega Engineering Ltd. is a specialized neuroscience and neurosurgery technology company developing advanced systems for neurophysiology research, deep brain stimulation (DBS) procedures, and clinical applications. The company manufactures microelectrode recording (MER) systems, brain mapping software, and DBS navigation tools used in human, primate, and rodent research settings, as well as in clinical neurosurgery and functional neurology. Their product portfolio includes portable and stationary MER systems with target localization capabilities, motorized commutators for free-moving animal studies, and neurological patient management platforms. Alpha Omega serves research institutions, neurosurgical centers, and clinical research organizations globally, supporting thousands of DBS procedures annually. The company emphasizes engineering precision, data reliability, and repeatability in neurophysiological signal acquisition. Their clinical research solutions integrate sophisticated hardware and software for brain mapping in both awake and asleep DBS procedures for the treatment of movement disorders and psychiatric conditions. Alpha Omega provides comprehensive customer support, technical engineering assistance, and training to optimize system implementation and clinical outcomes.

SoftWave TRT is a biomedical device manufacturer specializing in FDA-cleared electrohydraulic shockwave therapy systems for tissue regeneration, pain relief, and healing. Founded in 2004 and headquartered in Kennesaw, Georgia, the company has developed over 30 patents for its proprietary SoftWave® technology, which uses spark-initiated acoustic shockwaves to activate cellular healing responses including stem cell activation and improved blood flow without microtrauma. The flagship OrthoGold device and SoftWave Gold Li-Series platform are designed for orthopedic conditions, musculoskeletal pain, chronic diabetic foot ulcers, acute and chronic wounds, burns, and urological/pelvic health applications. The broad-focused, parallel-dispersion shockwave technology delivers results in 10–15 minute sessions with no downtime, and is deployed across leading medical institutions, university hospitals (Mayo Clinic, UCSF, UPMC), and professional sports organizations (MLB, NFL, NBA, NHL, MLS, NCAA, PGA, UFC). SoftWave TRT serves clinicians in sports medicine, orthopedics, wound care, physical therapy, chiropractic, dermatology, and integrative medicine practices.